01 5Ipsen Biopharmaceuticals Canada Inc.
01 52809374
01 5PALOVAROTENE
01 5CAPSULE
01 52031-08-31
Patent Expiration Date : 2031-08-31
Date Granted : 2021-02-23
Brand Name : SOHONOS
Patent Number : 2809374
Filing Date : 2011-08-31
Strength per Unit : 1mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-08-31
Date Granted : 2021-02-23
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-08-31
Date Granted : 2021-02-23
Brand Name : SOHONOS
Patent Number : 2809374
Filing Date : 2011-08-31
Strength per Unit : 1.5 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-08-31
Date Granted : 2021-02-23
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-08-31
Date Granted : 2021-02-23
Brand Name : SOHONOS
Patent Number : 2809374
Filing Date : 2011-08-31
Strength per Unit : 2.5 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-08-31
Date Granted : 2021-02-23
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-08-31
Date Granted : 2021-02-23
Brand Name : SOHONOS
Patent Number : 2809374
Filing Date : 2011-08-31
Strength per Unit : 5 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-08-31
Date Granted : 2021-02-23
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-08-31
Date Granted : 2021-02-23
Brand Name : SOHONOS
Patent Number : 2809374
Filing Date : 2011-08-31
Strength per Unit : 10 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-08-31
Date Granted : 2021-02-23
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
